All Stories

Caris Life Sciences collects $168M to fund tumor test rollouts

Caris' MI Cancer Seek assay, greenlit by the FDA in November, examines 228 tumor genes to help find eligible patients for targeted treatments.

Apr 9, 2025 - 17:19
 0
Caris Life Sciences collects $168M to fund tumor test rollouts
Caris' MI Cancer Seek assay, greenlit by the FDA in November, examines 228 tumor genes to help find eligible patients for targeted treatments.
Read More

Tags:

Previous Article

Economic Anxiety Alters American Travelers' Plans and Preferences

Next Article

Ferring gene therapy sales grow; ASH calls for restoration of cut CDC division

Related Posts

Teleflex plays musical chairs, plans company split amid €760M Biotronik cardiovascular deal

Teleflex plays musical chairs, plans company split amid...

Feb 27, 2025  0

Pyxis lays off 20% of staff to swing behind single-candidate strategy

Pyxis lays off 20% of staff to swing behind single-cand...

Mar 18, 2025  0

KalVista, awaiting FDA call on HAE drug, sells Japanese rights to Kaken in $22M deal

KalVista, awaiting FDA call on HAE drug, sells Japanese...

Apr 8, 2025  0